Cargando…

Acute Chagas Disease: New Global Challenges for an Old Neglected Disease

Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chagas disease,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade, Daniela V., Gollob, Kenneth J., Dutra, Walderez O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117453/ https://www.ncbi.nlm.nih.gov/pubmed/25077613 http://dx.doi.org/10.1371/journal.pntd.0003010

Ejemplares similares

T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies
por: de Souza-Silva, Thaiany Goulart, et al.
Publicado: (2022)

Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Balancing the functions of DNA extracellular traps in intracellular parasite infections: implications for host defense, disease pathology and therapy
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Distinct CD4(−)CD8(−) (Double-Negative) Memory T-Cell Subpopulations Are Associated With Indeterminate and Cardiac Clinical Forms of Chagas Disease
por: Passos, Livia Silva Araújo, et al.
Publicado: (2021)

Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area
por: Repetto, Ernestina Carla, et al.
Publicado: (2015)

The Role of Co-Stimulatory Molecules in Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

Prognosis of chronic Chagas heart disease and other pending clinical challenges
por: Torres, Rosália Morais, et al.
Publicado: (2022)

Activation of Human CD11b(+) B1 B-Cells by Trypanosoma cruzi-Derived Proteins Is Associated With Protective Immune Response in Human Chagas Disease
por: Passos, Livia Silva Araújo, et al.
Publicado: (2019)

Corrigendum: Activation of Human CD11b(+) B1 B-Cells by Trypanosoma cruzi-Derived Proteins Is Associated With Protective Immune Response in Human Chagas Disease
por: Passos, Livia Silva Araújo, et al.
Publicado: (2019)

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

Chagas Disease — An Underestimated Global Public Health Challenge
por: Liu, Qin, et al.
Publicado: (2020)

Neglected Parasitic Infections in the United States: Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2014)

Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!
por: Pinho, Rosa T., et al.
Publicado: (2016)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Challenges of addressing neglected tropical diseases amidst the COVID-19 pandemic in Africa: A case of Chagas Disease
por: Pradhan, Aishwarya Umesh, et al.
Publicado: (2022)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
por: Costa, Germano Carneiro, et al.
Publicado: (2020)

Extracellular Vesicles in Chagas Disease: A New Passenger for an Old Disease
por: de Pablos Torró, Luis M., et al.
Publicado: (2018)

Re: “Challenges of addressing neglected tropical diseases amidst the COVID-19 pandemic in Africa: A case of Chagas Disease”
por: Hasslocher-Moreno, Alejandro Marcel
Publicado: (2022)

Infection of Human Monocytes with Leishmania infantum Strains Induces a Downmodulated Response when Compared with Infection with Leishmania braziliensis
por: Viana, Agostinho Gonçalves, et al.
Publicado: (2018)

Diet Alters Serum Metabolomic Profiling in the Mouse Model of Chronic Chagas Cardiomyopathy
por: Lizardo, Kezia, et al.
Publicado: (2019)

Chagas disease treatment: a 120-year-old challenge to public health
por: Goldenberg, Samuel
Publicado: (2022)

T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
por: Neves, Eula G. A., et al.
Publicado: (2022)

CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

Acute Myopericarditis Secondary to Chagas Disease
por: Elizalde Uribe, Ivan A, et al.
Publicado: (2023)

1386. Chagas Disease in Chile: an Old and Forgotten
por: Novoa, Catalina, et al.
Publicado: (2023)

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi
por: Magalhães, Luísa M. D., et al.
Publicado: (2015)

Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017)

Evidence of Different IL-1β Activation Pathways in Innate Immune Cells From Indeterminate and Cardiac Patients With Chronic Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)

Chagas Disease Has Now Gone Global
por: Tanowitz, Herbert B., et al.
Publicado: (2011)

Putting Chagas disease on the global health agenda
Publicado: (2023)

Tungiasis—A Neglected Disease with Many Challenges for Global Public Health
por: Feldmeier, Hermann, et al.
Publicado: (2014)

MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)

Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease
por: Robledo, Sara M., et al.
Publicado: (2023)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Challenges and perspectives of Chagas disease: a review
por: Pereira, Paulo Câmara Marques, et al.
Publicado: (2013)

The translational challenge in Chagas disease drug development
por: Kratz, Jadel M, et al.
Publicado: (2022)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dvn3frlbv0n1r2isovr7e4lm7o